Covid third wave: A look at preparation of Centre & State Govts

The vaccine trials of Coaxin for children have been approved in India. On May 12, the country's Drug Controller General of India (DCGI) has accepted the recommendation of the Subject Expert Committee and has allowed the second and third clinical trials of the India Biotech's Coronavirus Vaccine. This clinical trial will be done in the age group of 2 to 18 years.